Study: Ozempic and Wegovy Reduce Household Food Spending and Change Purchasing Patterns
By
giuliomagnifico
The kind of bagel that ruins lesser bagels for you.
Summary
New research published in the Journal of Marketing Research shows that GLP-1 receptor agonist drugs like Ozempic and Wegovy are significantly changing American household food purchasing patterns. The study links survey data on drug use with transaction records from tens of thousands of households, revealing meaningful reductions in food spending at both grocery stores and restaurants. These appetite-suppressing medications are altering not just how much people eat, but also what specific foods they buy.
Key quotes
· 4 pulledWhen Americans begin taking appetite-suppressing drugs like Ozempic and Wegovy, the changes extend well beyond the bathroom scale.
According to new research, the medications are associated with meaningful reductions in how much households spend on food, both at the grocery store and at restaurants.
The study links survey data on GLP-1 receptor agonist use – a class of drugs originally developed for diabetes and now widely prescribed for weight loss – with detailed transaction records from tens of thousands of U.S. households.
The new class of weight-loss and diabetes drugs are changing not just how much American households are eating, but even precisely what they buy at a supermarket or restaurant.
You might also wanna read
GLP-1 Prescriptions Rise as U.S. Obesity Rates Show Modest Decline, New Data Indicates
New data from EPIC Research shows that GLP-1 medications like Ozempic and Wegovy are having a population-wide impact on obesity rates. As pr
gizmodo.com·2d ago
GLP-1 weight loss drugs reduce food spending, creating a $6.5 billion challenge for major grocery retailers
The article discusses how GLP-1 weight loss drugs like tirzepatide are significantly impacting consumer spending on food, creating a $6.5 bi
bit.ly·3d ago